Bulletin
Investor Alert

Bio-Techne Corp.

NAS: TECH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 14, 2021, 4:59 p.m.

/zigman2/quotes/203973516/composite

$

401.37

Change

0.00 0.00%

Volume

Volume 2,092

Quotes are delayed by 20 min

/zigman2/quotes/203973516/composite

Previous close

$ 396.34

$ 401.37

Change

+5.03 +1.27%

Day low

Day high

$395.58

$408.57

Open

52 week low

52 week high

$228.67

$444.83

Open

Insider Actions for Bio-Techne Corp.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/01/2021 Kim Kelderman
Pres. Diagnostics & Genom
856   Derivative/Non-derivative trans. at $427.49 per share. 365,931
05/01/2021 Kim Kelderman
Pres. Diagnostics & Genom
1,667   Derivative/Non-derivative trans. at $0 per share. 0
02/16/2021 Charles R. Kummeth
Chief Executive Officer; Director
17,428   Derivative/Non-derivative trans. at $411 per share. 7,162,908
02/16/2021 Charles R. Kummeth
Chief Executive Officer; Director
30,000   Derivative/Non-derivative trans. at $94.35 per share. 2,830,500
02/12/2021 James T. Hippel
Chief Financial Officer
600   Disposition at $401.52 per share. 240,912
02/12/2021 James T. Hippel
Chief Financial Officer
9,400   Disposition at $400.32 per share. 3,763,008
02/12/2021 Brenda Swierenga Furlow
SVP - General Counsel
3,326   Disposition at $399.12 per share. 1,327,473
02/12/2021 Brenda Swierenga Furlow
SVP - General Counsel
6,674   Disposition at $398.4 per share. 2,658,921
02/12/2021 James T. Hippel
Chief Financial Officer
10,000   Derivative/Non-derivative trans. at $106.59 per share. 1,065,900
02/12/2021 Brenda Swierenga Furlow
SVP - General Counsel
10,000   Derivative/Non-derivative trans. at $106.59 per share. 1,065,900
02/08/2021 Roeland Nusse
Director
6,000   Disposition at $385.08 per share. 2,310,480
02/08/2021 Roeland Nusse
Director
5,000   Derivative/Non-derivative trans. at $66.9 per share. 334,500
02/08/2021 Roeland Nusse
Director
1,000   Derivative/Non-derivative trans. at $70.35 per share. 70,350
02/05/2021 Kim Kelderman
Pres. Diagnostics & Genom
823   Disposition at $388.45 per share. 319,694
02/05/2021 Norman David Eansor
President-Protein Sciences
1,100   Disposition at $385.59 per share. 424,149
02/05/2021 Norman David Eansor
President-Protein Sciences
1,900   Disposition at $384.15 per share. 729,885
02/05/2021 Norman David Eansor
President-Protein Sciences
3,700   Disposition at $382.6 per share. 1,415,620
02/05/2021 Norman David Eansor
President-Protein Sciences
2,900   Disposition at $381.52 per share. 1,106,408
02/05/2021 Norman David Eansor
President-Protein Sciences
12,833   Disposition at $380.5 per share. 4,882,956
02/05/2021 Norman David Eansor
President-Protein Sciences
4,500   Disposition at $379.62 per share. 1,708,290
02/05/2021 Norman David Eansor
President-Protein Sciences
6,000   Disposition at $378.29 per share. 2,269,740
02/05/2021 Norman David Eansor
President-Protein Sciences
18,819   Derivative/Non-derivative trans. at $106.59 per share. 2,005,917
02/05/2021 Norman David Eansor
President-Protein Sciences
14,114   Derivative/Non-derivative trans. at $106.59 per share. 1,504,411
01/15/2021 Charles R. Kummeth
Chief Executive Officer; Director
20,000   Disposition at $344 per share. 6,880,000
01/11/2021 James T. Hippel
Chief Financial Officer
2,009   Disposition at $334.98 per share. 672,974
01/11/2021 James T. Hippel
Chief Financial Officer
3,990   Disposition at $334.39 per share. 1,334,216
01/11/2021 James T. Hippel
Chief Financial Officer
2,501   Disposition at $333.23 per share. 833,408
01/11/2021 James T. Hippel
Chief Financial Officer
700   Disposition at $331.61 per share. 232,127
01/11/2021 James T. Hippel
Chief Financial Officer
400   Disposition at $330.26 per share. 132,104
01/11/2021 James T. Hippel
Chief Financial Officer
400   Disposition at $328.68 per share. 131,472
01/11/2021 James T. Hippel
Chief Financial Officer
10,000   Derivative/Non-derivative trans. at $106.59 per share. 1,065,900
12/07/2020 Charles R. Kummeth
Chief Executive Officer; Director
5,000   Disposition at $308 per share. 1,540,000
11/30/2020 Brenda Swierenga Furlow
SVP - General Counsel
707   Disposition at $302.82 per share. 214,093
11/30/2020 Brenda Swierenga Furlow
SVP - General Counsel
6,783   Disposition at $302.15 per share. 2,049,483
11/30/2020 Brenda Swierenga Furlow
SVP - General Counsel
3,367   Disposition at $301.32 per share. 1,014,544
11/30/2020 Brenda Swierenga Furlow
SVP - General Counsel
938   Derivative/Non-derivative trans. at $106.59 per share. 99,981
11/30/2020 Brenda Swierenga Furlow
SVP - General Counsel
10,857   Derivative/Non-derivative trans. at $106.59 per share. 1,157,247
11/18/2020 Robert V. Baumgartner
Director
5,000   Disposition at $303.34 per share. 1,516,700
11/18/2020 Robert V. Baumgartner
Director
5,000   Derivative/Non-derivative trans. at $66.9 per share. 334,500

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
1 Sales
1,667
856
Last 6 months
12 Purchases
27 Sales
117,395
128,897
Last 12 months
49 Purchases
98 Sales
336,796
303,899

Officers and Executives

Mr. Charles R. Kummeth
President, Chief Executive Officer & Director
Mr. James T. Hippel
CFO & Principal Accounting Officer
Dr. Robert Monroe
Chief Medical Officer
Mr. Kim Kelderman
President-Diagnostics & Genomics
Ms. Brenda Swierenga Furlow
Secretary, Senior Vice President & General Counsel
Mr. Robert M. Gavin
Senior Vice President-Analytical Systems Division
Mr. Kevin S. Gould
Senior Vice President-Diagnostics Division
Mr. David Clair
Senior Director-Investor Relations
Mr. Struan Robertson
Vice President–Human Resources
Mr. Robert V. Baumgartner
Chairman
Dr. Rupert J. Vessey
Independent Director
Ms. Julie L. Bushman
Independent Director
Dr. Randolph C. Steer
Independent Director
Mr. John L. Higgins
Independent Director
Dr. Roeland Nusse
Independent Director
Dr. Alpna H. Seth
Independent Director
Dr. Joseph D. Keegan
Independent Director
Link to MarketWatch's Slice.